D. E. Shaw & Co., Inc. Edwards Lifesciences Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 983,216 shares of EW stock, worth $74.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

983,216

Holding current value

$74.1 Million

% of portfolio

0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $53.3 Million - $83.8 Million	893,566 Added 996.73%	983,216 $64.9 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $15 Million - $16.8 Million	-177,934 Reduced 66.5%	89,650 $8.28 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $2.02 Million - $2.66 Million	27,795 Added 11.59%	267,584 $25.6 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $11.3 Million - $14.3 Million	-183,440 Reduced 43.34%	239,789 $18.3 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $5.86 Million - $7.9 Million	-84,632 Reduced 16.66%	423,229 $29.3 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $205 Million - $238 Million	-2,520,545 Reduced 83.23%	507,861 $47.9 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $16.2 Million - $18.4 Million	218,112 Added 7.76%	3,028,406 $251 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $162 Million - $207 Million	2,367,796 Added 535.1%	2,810,294 $210 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $34.1 Million - $44.4 Million	414,199 Added 1463.65%	442,498 $36.6 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $856,869 - $1.27 Million	9,906 Added 53.86%	28,299 $2.69 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $3.53 Million - $4.44 Million	-34,604 Reduced 65.29%	18,393 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $19.2 Million - $23.6 Million	-180,423 Reduced 77.3%	52,997 $6.87 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $29 Million - $34.6 Million	-281,725 Reduced 54.69%	233,420 $26.4 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $44.3 Million - $55.4 Million	-528,706 Reduced 50.65%	515,145 $53.4 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $64.8 Million - $74.7 Million	824,058 Added 374.92%	1,043,851 $87.3 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $36.1 Million - $45.9 Million	-503,450 Reduced 69.61%	219,793 $20.1 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $16.7 Million - $21.7 Million	-248,142 Reduced 25.55%	723,243 $57.7 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $33.3 Million - $44.5 Million	578,747 Added 147.4%	971,385 $67.1 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $18.2 Million - $28.1 Million	346,753 Added 755.7%	392,638 $74.1 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $2.13 Million - $2.43 Million	29,651 Added 182.65%	45,885 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $3.37 Million - $4.12 Million	-54,674 Reduced 77.11%	16,234 $3.57 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $3.05 Million - $3.52 Million	54,716 Added 337.92%	70,908 $13.1 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $262,772 - $351,442	-5,487 Reduced 25.31%	16,192 $3.1 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $6.34 Million - $7.78 Million	-136,598 Reduced 86.3%	21,679 $3.32 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $11.4 Million - $14.5 Million	-250,167 Reduced 61.25%	158,277 $27.6 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $3.13 Million - $3.78 Million	-73,735 Reduced 15.29%	408,444 $59.5 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $6.71 Million - $8.57 Million	180,510 Added 59.84%	482,179 $67.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $1.99 Million - $2.32 Million	58,945 Added 24.28%	301,669 $34 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $8.81 Million - $9.42 Million	242,724	242,724 $26.5 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account